ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
The University of Texas at Austin at ACR Convergence 2026
Nov 6–11, 2026 Orlando, FL ~15k attendees Website
The University of Texas at Austin brings 6 presentations to ACR Convergence 2026 in Orlando. Its program centres on vasculitis, including polymyalgia rheumatica, giant cell arteritis and Behçet syndrome. It also covers real-world psoriatic arthritis treatment patterns and a basic science video curriculum for rheumatology trainees.
| Organization | ACR Convergence 2026 Attendance |
|---|---|
The University of Texas at Austin Austin, TX | |
A public research university whose Dell Medical School trains physicians and runs clinical research in Austin. | Session Sun Nov 8 1:00pm–2:30pm Improving Outcomes for Patients with Polymyalgia (PMR) & Giant Cell Arteritis (GCA)
Session Tue Nov 10 10:00am–11:30am Beyond the Guidelines: Updated Management of Systemic Vasculitis
Poster Tue Nov 10 10:30am–12:30pm Poster Tue Nov 10 10:30am–12:30pm Industry Tue Nov 10 11:30am–12:15pm Bridging the Age Gap: Recognizing MAS Before it is Too Late Session Wed Nov 11 8:00am–9:30am Behçet Syndrome: Updates in Pathogenesis, Diagnosis, and Management
|
Find decision makers at The University of Texas at Austin
Tell us what you sell and we’ll find the people at The University of Texas at Austin most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction